BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29270231)

  • 1. Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment.
    Stamuli E; Torgerson D; Northgraves M; Ronaldson S; Cherry L
    J Foot Ankle Res; 2017; 10():57. PubMed ID: 29270231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
    Augustovski F; Beratarrechea A; Irazola V; Rubinstein F; Tesolin P; Gonzalez J; Lencina V; Scolnik M; Waimann C; Navarta D; Citera G; Soriano ER
    Value Health; 2013; 16(2):385-93. PubMed ID: 23538191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Husni ME; Betts KA; Griffith J; Song Y; Ganguli A
    Rheumatol Int; 2017 Sep; 37(9):1423-1434. PubMed ID: 28623526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment.
    Ho KA; Acar M; Puig A; Hutas G; Fifer S
    Clin Rheumatol; 2020 Apr; 39(4):1077-1089. PubMed ID: 31858340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment.
    Hendry GJ; Turner DE; Gardner-Medwin J; Lorgelly PK; Woodburn J
    J Foot Ankle Res; 2014 Feb; 7(1):10. PubMed ID: 24502508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment.
    Kopasker D; Kwiatkowski A; Matin RN; Harwood CA; Ismail F; Lear JT; Thomson J; Hasan Z; Wali GN; Milligan A; Crawford L; Ahmed I; Duffy H; Proby CM; Allanson PF
    Br J Dermatol; 2019 Apr; 180(4):902-909. PubMed ID: 29782648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals.
    Harrison M; Spooner L; Bansback N; Milbers K; Koehn C; Shojania K; Finckh A; Hudson M
    PLoS One; 2019; 14(4):e0216075. PubMed ID: 31022252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis.
    DiSantostefano RL; Simons G; Englbrecht M; Humphreys JH; Bruce IN; Bywall KS; Radawski C; Raza K; Falahee M; Veldwijk J
    Med Decis Making; 2024 Feb; 44(2):189-202. PubMed ID: 38240281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.
    Hazlewood GS; Bombardier C; Tomlinson G; Thorne C; Bykerk VP; Thompson A; Tin D; Marshall DA
    Rheumatology (Oxford); 2016 Nov; 55(11):1959-1968. PubMed ID: 27477807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological considerations for a randomised controlled trial of podiatry care in rheumatoid arthritis: lessons from an exploratory trial.
    Turner DE; Helliwell PS; Woodburn J
    BMC Musculoskelet Disord; 2007 Nov; 8():109. PubMed ID: 17986338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
    Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
    J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review.
    Durand C; Eldoma M; Marshall DA; Bansback N; Hazlewood GS
    J Rheumatol; 2020 Feb; 47(2):176-187. PubMed ID: 30988125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an online self-management tool, OPERAS (an On-demand Program to EmpoweR Active Self-management), for people with rheumatoid arthritis: a research protocol.
    Tam J; Lacaille D; Liu-Ambrose T; Shaw C; Xie H; Backman CL; Esdaile JM; Miller K; Petrella R; Li LC
    Trials; 2019 Dec; 20(1):712. PubMed ID: 31829286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies.
    Vass CM; Davison NJ; Vander Stichele G; Payne K
    Patient; 2020 Apr; 13(2):163-173. PubMed ID: 31565784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Item Development and Face Validity of the Rheumatoid Arthritis Patient Priorities in Pharmacological Interventions Outcome Measures.
    Sanderson T; Kirwan J; Almeida C; Morris M; Noddings R; Hewlett S
    Patient; 2016 Apr; 9(2):103-15. PubMed ID: 26113248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
    Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
    Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.
    Alten R; Nieto-Gonzalez JC; Jacques P; Montecucco C; Moots R; Radner H; Vonkeman HE; Heidenreich S; Whichello C; Krucien N; Van Beneden K
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.